Tenofovir decrease hepatocellular carcinoma recurrence in chronic hepatitis B patients after liver resection

Tenofovir decrease hepatocellular carcinoma recurrence in chronic hepatitis B patients after liver resection

Abstract Background Tenofovir disoproxil fumarate (TDF) and entecavir (ETV) are recommended as the first-line choices regarding the treatment of chronic hepatits B. The impact of the two antiviral agents on prognosis of Chronic hepatitis B (CHB) related hepatocellular carcinoma (HCC) remains to be e...

Full description

Bibliographic Details
Main Authors: Min Zhang, Dexin Wang, Haidong Liu, Hui Li
Format: Article
Language:English
Published: BMC 2018-06-01
Series:Infectious Agents and Cancer
Subjects:
Tenofovir
Entecavir
Chronic hepatits B
Hepatocellular carcinoma
Nucleus(t)ide analogues
Online Access:http://link.springer.com/article/10.1186/s13027-018-0191-8

Internet

http://link.springer.com/article/10.1186/s13027-018-0191-8

Similar Items